Business Description
Siemens Healthineers AG
ISIN : DE000SHL1006
Share Class Description:
XBUL:SHL: Registered SharesCompare
Compare
Traded in other countries / regions
SHL.Germany0PMJ.UKSMMNY.USA1SHL.ItalySHL.AustriaSHL.BulgariaSHL.SwitzerlandSHL.Mexico IPO Date
2021-12-09Description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.13 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | 6.24 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.99 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 5.9 | |||||
| 3-Year EPS without NRI Growth Rate | -0.9 | |||||
| 3-Year FCF Growth Rate | -5.8 | |||||
| 3-Year Book Growth Rate | 11.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 28.09 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.65 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 119.79 | |||||
| Days Sales Outstanding | 69.35 | |||||
| Days Payable | 54.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.85 | |||||
| Dividend Payout Ratio | 0.57 | |||||
| 3-Year Dividend Growth Rate | 5.9 | |||||
| Forward Dividend Yield % | 3.85 | |||||
| 5-Year Yield-on-Cost % | 3.85 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | 1.99 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.82 | |||||
| Operating Margin % | 12.32 | |||||
| Net Margin % | 8.43 | |||||
| FCF Margin % | 6.59 | |||||
| ROE % | 10.35 | |||||
| ROA % | 4.04 | |||||
| ROIC % | 5.37 | |||||
| 3-Year ROIIC % | 1.49 | |||||
| ROC (Joel Greenblatt) % | 68.52 | |||||
| ROCE % | 8.56 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.99 | |||||
| Forward PE Ratio | 9.7 | |||||
| PE Ratio without NRI | 29.99 | |||||
| Price-to-Owner-Earnings | 24.9 | |||||
| PEG Ratio | 4.41 | |||||
| PS Ratio | 2.53 | |||||
| PB Ratio | 3.05 | |||||
| Price-to-Free-Cash-Flow | 38.27 | |||||
| Price-to-Operating-Cash-Flow | 25.6 | |||||
| EV-to-EBIT | 18.71 | |||||
| EV-to-Forward-EBIT | 16.07 | |||||
| EV-to-EBITDA | 13.08 | |||||
| EV-to-Forward-EBITDA | 11.5 | |||||
| EV-to-Revenue | 2.45 | |||||
| EV-to-Forward-Revenue | 2.26 | |||||
| EV-to-FCF | 37.21 | |||||
| Price-to-Projected-FCF | 1.76 | |||||
| Earnings Yield (Greenblatt) % | 5.35 | |||||
| FCF Yield % | 2.62 | |||||
| Forward Rate of Return (Yacktman) % | 7.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Siemens Healthineers AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil лв) | 42,101.281 | ||
| EPS (TTM) (лв) | 3.162 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (лв) | 0.152366 | ||
| 20-Day SMA (лв) | 48.44 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (лв) | 48.44 - 48.87 | ||
| Shares Outstanding (Mil) | 1,118.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Siemens Healthineers AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Siemens Healthineers AG Stock Events
| Event | Date | Price(лв) | ||
|---|---|---|---|---|
| No Event Data | ||||
Siemens Healthineers AG Frequently Asked Questions
What is Siemens Healthineers AG(XBUL:SHL)'s stock price today?
The current price of XBUL:SHL is лв48.44. The 52 week high of XBUL:SHL is лв48.87 and 52 week low is лв48.44.
When is next earnings date of Siemens Healthineers AG(XBUL:SHL)?
The next earnings date of Siemens Healthineers AG(XBUL:SHL) is 2024-11-06.
Does Siemens Healthineers AG(XBUL:SHL) pay dividends? If so, how much?
The Dividend Yield %  of Siemens Healthineers AG(XBUL:SHL) is 3.85% (As of Today), Highest Dividend Payout Ratio of Siemens Healthineers AG(XBUL:SHL) was 0.71. The lowest was 0.45. And the median was 0.51. The  Forward Dividend Yield % of Siemens Healthineers AG(XBUL:SHL) is 3.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers